Does Dr. ALICIA ALEXANDER have financial conflicts of interest?

Dr. ALICIA ALEXANDER (CPNP, PMHS) has received a total of $513 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $513 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ALICIA ALEXANDER?

According to CMS Open Payments data, Dr. ALICIA ALEXANDER received funding from SUPERNUS PHARMACEUTICALS ($170), OTSUKA AMERICA PHARMACEUTICAL ($149), and MYLAN SPECIALTY L.P ($63).

Does Dr. ALICIA ALEXANDER receive research grants or speaking fees?

Dr. ALICIA ALEXANDER has received $513 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ALICIA ALEXANDER

CPNP, PMHSReal-Time Hydrated

Specialty: Clinical Nurse Specialist, Pediatrics

Practice Location: ONEIDA, TN 37841

NPI Number: 1952684268

LIFETIME INDUSTRY VALUE

$513

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ALEXANDER is a verified Clinical Nurse Specialist, Pediatrics practitioner based in ONEIDA, TN.

Between 2021 and 2025, Dr. ALEXANDER had an overall industry promotional and research financial footprint of $513 as recorded in the federal CMS Open Payments database.

$513 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ALEXANDER's primary funding source is SUPERNUS PHARMACEUTICALS, which accounts for $170 (representing 33.2% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

SUPERNUS PHARMACEUTICALS

Rank 1

$170

33.2%

OTSUKA AMERICA PHARMACEUTICAL

Rank 2

$149

29.1%

MYLAN SPECIALTY L.P

Rank 3

$63

12.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.